MWPCG
RGEN icon

Measured Wealth Private Client Group’s Repligen RGEN Stock Holding History

Measured Wealth Private Client Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Sell
182
-33
-15% -$4.05K 0.01% 453
2026
Q1 		$25.3K Hold
215
– – 0.01% 424
2025
Q4 		$35.2K Hold
215
– – 0.01% 360
2025
Q3 		$28.7K Buy
+215
New +$26.1K 0.01% 398

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Measured Wealth Private Client Group's RGEN Position: Q2 2026 in Review

Measured Wealth Private Client Group reduced its Repligen (RGEN) stake by 15% in Q2 2026, selling an estimated $4.05K and leaving 182 shares worth $24.8K. The position accounts for 0.01% of the portfolio, ranked #453.

Measured Wealth Private Client Group first reported a position in RGEN in Q3 2025 and has held it in 4 quarters since. The position peaked at $35.2K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Measured Wealth Private Client Group held 182 shares of Repligen worth $24.8K as of Q2 2026.
  • Measured Wealth Private Client Group sold 33 Repligen shares in Q2 2026, an estimated $4.05K.
  • Repligen made up 0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #453 holding.
  • Measured Wealth Private Client Group first reported a position in Repligen in Q3 2025 and has held it in 4 quarters since.
  • Measured Wealth Private Client Group's Repligen position peaked at $35.2K in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.